Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neurogen closes $30.6 million financing to advance clinical programs
The $30.6 million offering was for the sale of 981,411 units. Each unit consists of one share of exchangeable preferred stock and a warrant to acquire additional shares
The $30.6 million offering was for the sale of 981,411 units. Each unit consists of one share of exchangeable preferred stock and a warrant to acquire additional shares
The test would also employ certain proprietary reagents belonging to Bio-Rad. The agreement contemplates that the parties would enter into a limited exclusive license to the DPP technology.
According to IMS Health, US with $286.5 billion in sales, accounted for 25.5% of the total sector despite its low prescription drug turnover of 3.8% in 2007. Although
The Paris office is its ninth office abroad and the company has appointed Horia Vilcu, the former director of Walmark’s subsidiary in Romania, as its head. The company
According to the DIA, the biopharmaceutical industry in India will be worth $1 billion by 2010, up from $60 million in 2003 and $100 million in 2006. The
The company and Apex Bioventures determined that, due to current market conditions, particularly for small capitalization public biotech companies’s, terminating the merger agreement was in the best interests
Dr Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company which was acquired by Genentech in 2007. Dr Chen holds a PhD from
Repligen is currently conducting a Phase III clinical trial to assess the sensitivity and specificity of secretin-enhanced magnetic resonance imaging (MRI) to improve the ability to detect pancreatic
Biomoda’s innovative, non-invasive technology is designed for early lung cancer screening of large populations at a reasonable cost. With the technology, clinicians can identify cancerous or aberrant cells
The Talent Abdominal Stent Graft System is said to make endovascular repair accessible to an additional 20% of abdominal aortic aneurysm patients, because of its unique proximal aortic